Showing results (61-70 of 105) with videos related to
Sort By:
Pageof 11
Cell Death & Disease|May 30, 2023
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1Rui Yang, Liangliang Li, Yumeng Hou, et al.Computational and Structural Biotechnology Journal|September 2, 2021
Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genomeQi Dong, Mingyue Liu, Bo Chen, et al.Theranostics|March 5, 2021
Erratum: LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d: ErratumHaihai Liang, Zhenwei Pan, Xiaoguang Zhao, et al.Journal of Cellular Physiology|July 14, 2020
Suppression of Sox4 protects against myocardial ischemic injury by reduction of cardiac apoptosis in miceLijia Zhang, Lifang Lv, Nan Zheng, et al.JCI Insight|November 8, 2023
Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathwayQi Dong, Tong Yu, Bo Chen, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 8, 2016
MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial FibrosisWeijie Du, Haihai Liang, Xu Gao, et al.British Journal of Cancer|May 26, 2022
Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockadeTingting Chen, Tong Yu, Shuping Zhuang, et al.Theranostics|February 22, 2018
LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7dHaihai Liang, Zhenwei Pan, Xiaoguang Zhao, et al.Cell Death and Differentiation|May 13, 2021
The long non-coding RNA PFI protects against pulmonary fibrosis by interacting with splicing regulator SRSF1Jian Sun, Tongzhu Jin, Wei Su, et al.Genome Medicine|June 17, 2026
DISCERN: inferring drug sensitivity from single-cell transcriptomes using cell-type-specific genetic interaction networksMingyue Liu, Yu Tian, Yuchao Jia, et al.Pageof 11